img

Global TB Disease Vaccine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global TB Disease Vaccine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

The vaccine for tuberculosis (TB) is known as BCG (bacille Calmette-Guérin) vaccine. BCG vaccine contains a weakened form of the bacteria (germ) that cause TB. Because it is weakened it doesn't cause TB in healthy people but it helps develop some protection (immunity) against TB.
TB Disease Vaccine report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global TB Disease Vaccine market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Self-Procurement and UNICEF are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for TB Disease Vaccine industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, TB Disease Vaccine key manufacturers include Merck, Japan BCG Lab, Serum Institute of India, AJ Vaccines, BioFarma, GreenSignal Bio Pharma, China National Biotec, Biomed Lublin and Taj Pharmaceuticals, etc. Merck, Japan BCG Lab, Serum Institute of India are top 3 players and held % sales share in total in 2022.
TB Disease Vaccine can be divided into Prevention Vaccines, Post-exposure Vaccines and Others,, etc. Prevention Vaccines is the mainstream product in the market, accounting for % sales share globally in 2022.
TB Disease Vaccine is widely used in various fields, such as Self-Procurement, UNICEF and Others,, etc. Self-Procurement provides greatest supports to the TB Disease Vaccine industry development. In 2022, global % sales of TB Disease Vaccine went into Self-Procurement filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global TB Disease Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Merck
Japan BCG Lab
Serum Institute of India
AJ Vaccines
BioFarma
GreenSignal Bio Pharma
China National Biotec
Biomed Lublin
Taj Pharmaceuticals
Ataulpho de Paiva
IVAC
Queen Saovabha Mem. Inst
Microgen
Segment by Type
Prevention Vaccines
Post-exposure Vaccines
Others

Segment by Application


Self-Procurement
UNICEF
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the TB Disease Vaccine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of TB Disease Vaccine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the TB Disease Vaccine industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of TB Disease Vaccine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, TB Disease Vaccine introduction, etc. TB Disease Vaccine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of TB Disease Vaccine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 TB Disease Vaccine Market Overview
1.1 TB Disease Vaccine Product Overview
1.2 TB Disease Vaccine Market Segment by Type
1.2.1 Prevention Vaccines
1.2.2 Post-exposure Vaccines
1.2.3 Others
1.3 Global TB Disease Vaccine Market Size by Type
1.3.1 Global TB Disease Vaccine Market Size Overview by Type (2018-2034)
1.3.2 Global TB Disease Vaccine Historic Market Size Review by Type (2018-2024)
1.3.3 Global TB Disease Vaccine Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America TB Disease Vaccine Sales Breakdown by Type (2018-2024)
1.4.2 Europe TB Disease Vaccine Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific TB Disease Vaccine Sales Breakdown by Type (2018-2024)
1.4.4 Latin America TB Disease Vaccine Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa TB Disease Vaccine Sales Breakdown by Type (2018-2024)
2 Global TB Disease Vaccine Market Competition by Company
2.1 Global Top Players by TB Disease Vaccine Sales (2018-2024)
2.2 Global Top Players by TB Disease Vaccine Revenue (2018-2024)
2.3 Global Top Players by TB Disease Vaccine Price (2018-2024)
2.4 Global Top Manufacturers TB Disease Vaccine Manufacturing Base Distribution, Sales Area, Product Type
2.5 TB Disease Vaccine Market Competitive Situation and Trends
2.5.1 TB Disease Vaccine Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by TB Disease Vaccine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in TB Disease Vaccine as of 2022)
2.7 Date of Key Manufacturers Enter into TB Disease Vaccine Market
2.8 Key Manufacturers TB Disease Vaccine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 TB Disease Vaccine Status and Outlook by Region
3.1 Global TB Disease Vaccine Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global TB Disease Vaccine Historic Market Size by Region
3.2.1 Global TB Disease Vaccine Sales in Volume by Region (2018-2024)
3.2.2 Global TB Disease Vaccine Sales in Value by Region (2018-2024)
3.2.3 Global TB Disease Vaccine Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global TB Disease Vaccine Forecasted Market Size by Region
3.3.1 Global TB Disease Vaccine Sales in Volume by Region (2024-2034)
3.3.2 Global TB Disease Vaccine Sales in Value by Region (2024-2034)
3.3.3 Global TB Disease Vaccine Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global TB Disease Vaccine by Application
4.1 TB Disease Vaccine Market Segment by Application
4.1.1 Self-Procurement
4.1.2 UNICEF
4.1.3 Others
4.2 Global TB Disease Vaccine Market Size by Application
4.2.1 Global TB Disease Vaccine Market Size Overview by Application (2018-2034)
4.2.2 Global TB Disease Vaccine Historic Market Size Review by Application (2018-2024)
4.2.3 Global TB Disease Vaccine Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America TB Disease Vaccine Sales Breakdown by Application (2018-2024)
4.3.2 Europe TB Disease Vaccine Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific TB Disease Vaccine Sales Breakdown by Application (2018-2024)
4.3.4 Latin America TB Disease Vaccine Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa TB Disease Vaccine Sales Breakdown by Application (2018-2024)
5 North America TB Disease Vaccine by Country
5.1 North America TB Disease Vaccine Historic Market Size by Country
5.1.1 North America TB Disease Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America TB Disease Vaccine Sales in Volume by Country (2018-2024)
5.1.3 North America TB Disease Vaccine Sales in Value by Country (2018-2024)
5.2 North America TB Disease Vaccine Forecasted Market Size by Country
5.2.1 North America TB Disease Vaccine Sales in Volume by Country (2024-2034)
5.2.2 North America TB Disease Vaccine Sales in Value by Country (2024-2034)
6 Europe TB Disease Vaccine by Country
6.1 Europe TB Disease Vaccine Historic Market Size by Country
6.1.1 Europe TB Disease Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe TB Disease Vaccine Sales in Volume by Country (2018-2024)
6.1.3 Europe TB Disease Vaccine Sales in Value by Country (2018-2024)
6.2 Europe TB Disease Vaccine Forecasted Market Size by Country
6.2.1 Europe TB Disease Vaccine Sales in Volume by Country (2024-2034)
6.2.2 Europe TB Disease Vaccine Sales in Value by Country (2024-2034)
7 Asia-Pacific TB Disease Vaccine by Region
7.1 Asia-Pacific TB Disease Vaccine Historic Market Size by Region
7.1.1 Asia-Pacific TB Disease Vaccine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific TB Disease Vaccine Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific TB Disease Vaccine Sales in Value by Region (2018-2024)
7.2 Asia-Pacific TB Disease Vaccine Forecasted Market Size by Region
7.2.1 Asia-Pacific TB Disease Vaccine Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific TB Disease Vaccine Sales in Value by Region (2024-2034)
8 Latin America TB Disease Vaccine by Country
8.1 Latin America TB Disease Vaccine Historic Market Size by Country
8.1.1 Latin America TB Disease Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America TB Disease Vaccine Sales in Volume by Country (2018-2024)
8.1.3 Latin America TB Disease Vaccine Sales in Value by Country (2018-2024)
8.2 Latin America TB Disease Vaccine Forecasted Market Size by Country
8.2.1 Latin America TB Disease Vaccine Sales in Volume by Country (2024-2034)
8.2.2 Latin America TB Disease Vaccine Sales in Value by Country (2024-2034)
9 Middle East and Africa TB Disease Vaccine by Country
9.1 Middle East and Africa TB Disease Vaccine Historic Market Size by Country
9.1.1 Middle East and Africa TB Disease Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa TB Disease Vaccine Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa TB Disease Vaccine Sales in Value by Country (2018-2024)
9.2 Middle East and Africa TB Disease Vaccine Forecasted Market Size by Country
9.2.1 Middle East and Africa TB Disease Vaccine Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa TB Disease Vaccine Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Merck
10.1.1 Merck Company Information
10.1.2 Merck Introduction and Business Overview
10.1.3 Merck TB Disease Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Merck TB Disease Vaccine Products Offered
10.1.5 Merck Recent Development
10.2 Japan BCG Lab
10.2.1 Japan BCG Lab Company Information
10.2.2 Japan BCG Lab Introduction and Business Overview
10.2.3 Japan BCG Lab TB Disease Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Japan BCG Lab TB Disease Vaccine Products Offered
10.2.5 Japan BCG Lab Recent Development
10.3 Serum Institute of India
10.3.1 Serum Institute of India Company Information
10.3.2 Serum Institute of India Introduction and Business Overview
10.3.3 Serum Institute of India TB Disease Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Serum Institute of India TB Disease Vaccine Products Offered
10.3.5 Serum Institute of India Recent Development
10.4 AJ Vaccines
10.4.1 AJ Vaccines Company Information
10.4.2 AJ Vaccines Introduction and Business Overview
10.4.3 AJ Vaccines TB Disease Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.4.4 AJ Vaccines TB Disease Vaccine Products Offered
10.4.5 AJ Vaccines Recent Development
10.5 BioFarma
10.5.1 BioFarma Company Information
10.5.2 BioFarma Introduction and Business Overview
10.5.3 BioFarma TB Disease Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.5.4 BioFarma TB Disease Vaccine Products Offered
10.5.5 BioFarma Recent Development
10.6 GreenSignal Bio Pharma
10.6.1 GreenSignal Bio Pharma Company Information
10.6.2 GreenSignal Bio Pharma Introduction and Business Overview
10.6.3 GreenSignal Bio Pharma TB Disease Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.6.4 GreenSignal Bio Pharma TB Disease Vaccine Products Offered
10.6.5 GreenSignal Bio Pharma Recent Development
10.7 China National Biotec
10.7.1 China National Biotec Company Information
10.7.2 China National Biotec Introduction and Business Overview
10.7.3 China National Biotec TB Disease Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.7.4 China National Biotec TB Disease Vaccine Products Offered
10.7.5 China National Biotec Recent Development
10.8 Biomed Lublin
10.8.1 Biomed Lublin Company Information
10.8.2 Biomed Lublin Introduction and Business Overview
10.8.3 Biomed Lublin TB Disease Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Biomed Lublin TB Disease Vaccine Products Offered
10.8.5 Biomed Lublin Recent Development
10.9 Taj Pharmaceuticals
10.9.1 Taj Pharmaceuticals Company Information
10.9.2 Taj Pharmaceuticals Introduction and Business Overview
10.9.3 Taj Pharmaceuticals TB Disease Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Taj Pharmaceuticals TB Disease Vaccine Products Offered
10.9.5 Taj Pharmaceuticals Recent Development
10.10 Ataulpho de Paiva
10.10.1 Ataulpho de Paiva Company Information
10.10.2 Ataulpho de Paiva Introduction and Business Overview
10.10.3 Ataulpho de Paiva TB Disease Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Ataulpho de Paiva TB Disease Vaccine Products Offered
10.10.5 Ataulpho de Paiva Recent Development
10.11 IVAC
10.11.1 IVAC Company Information
10.11.2 IVAC Introduction and Business Overview
10.11.3 IVAC TB Disease Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.11.4 IVAC TB Disease Vaccine Products Offered
10.11.5 IVAC Recent Development
10.12 Queen Saovabha Mem. Inst
10.12.1 Queen Saovabha Mem. Inst Company Information
10.12.2 Queen Saovabha Mem. Inst Introduction and Business Overview
10.12.3 Queen Saovabha Mem. Inst TB Disease Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Queen Saovabha Mem. Inst TB Disease Vaccine Products Offered
10.12.5 Queen Saovabha Mem. Inst Recent Development
10.13 Microgen
10.13.1 Microgen Company Information
10.13.2 Microgen Introduction and Business Overview
10.13.3 Microgen TB Disease Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Microgen TB Disease Vaccine Products Offered
10.13.5 Microgen Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 TB Disease Vaccine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 TB Disease Vaccine Industrial Chain Analysis
11.4 TB Disease Vaccine Market Dynamics
11.4.1 TB Disease Vaccine Industry Trends
11.4.2 TB Disease Vaccine Market Drivers
11.4.3 TB Disease Vaccine Market Challenges
11.4.4 TB Disease Vaccine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 TB Disease Vaccine Distributors
12.3 TB Disease Vaccine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Prevention Vaccines
Table 2. Major Company of Post-exposure Vaccines
Table 3. Major Company of Others
Table 4. Global TB Disease Vaccine Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 5. Global TB Disease Vaccine Sales by Type (2018-2024) & (K Units)
Table 6. Global TB Disease Vaccine Sales Market Share in Volume by Type (2018-2024)
Table 7. Global TB Disease Vaccine Sales by Type (2018-2024) & (US& Million)
Table 8. Global TB Disease Vaccine Market Share in Value by Type (2018-2024)
Table 9. Global TB Disease Vaccine Price by Type (2018-2024) & (US$/Unit)
Table 10. Global TB Disease Vaccine Sales by Type (2024-2034) & (K Units)
Table 11. Global TB Disease Vaccine Sales Market Share in Volume by Type (2024-2034)
Table 12. Global TB Disease Vaccine Sales by Type (2024-2034) & (US$ Million)
Table 13. Global TB Disease Vaccine Sales Market Share in Value by Type (2024-2034)
Table 14. Global TB Disease Vaccine Price by Type (2024-2034) & (US$/Unit)
Table 15. North America TB Disease Vaccine Sales by Type (2018-2024) & (K Units)
Table 16. North America TB Disease Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 17. Europe TB Disease Vaccine Sales (K Units) by Type (2018-2024)
Table 18. Europe TB Disease Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 19. Asia-Pacific TB Disease Vaccine Sales (K Units) by Type (2018-2024)
Table 20. Asia-Pacific TB Disease Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 21. Latin America TB Disease Vaccine Sales (K Units) by Type (2018-2024)
Table 22. Latin America TB Disease Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 23. Middle East and Africa TB Disease Vaccine Sales (K Units) by Type (2018-2024)
Table 24. Middle East and Africa TB Disease Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 25. Global TB Disease Vaccine Sales by Company (2018-2024) & (K Units)
Table 26. Global TB Disease Vaccine Sales Share by Company (2018-2024)
Table 27. Global TB Disease Vaccine Revenue by Company (2018-2024) & (US$ Million)
Table 28. Global TB Disease Vaccine Revenue Share by Company (2018-2024)
Table 29. Global Market TB Disease Vaccine Price by Company (2018-2024) & (US$/Unit)
Table 30. Global TB Disease Vaccine Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global TB Disease Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in TB Disease Vaccine as of 2022)
Table 33. Date of Key Manufacturers Enter into TB Disease Vaccine Market
Table 34. Key Manufacturers TB Disease Vaccine Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global TB Disease Vaccine Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 37. Global TB Disease Vaccine Sales by Region (2018-2024) & (K Units)
Table 38. Global TB Disease Vaccine Sales Market Share in Volume by Region (2018-2024)
Table 39. Global TB Disease Vaccine Sales by Region (2018-2024) & (US$ Million)
Table 40. Global TB Disease Vaccine Sales Market Share in Value by Region (2018-2024)
Table 41. Global TB Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 42. Global TB Disease Vaccine Sales by Region (2024-2034) & (K Units)
Table 43. Global TB Disease Vaccine Sales Market Share in Volume by Region (2024-2034)
Table 44. Global TB Disease Vaccine Sales by Region (2024-2034) & (US$ Million)
Table 45. Global TB Disease Vaccine Sales Market Share in Value by Region (2024-2034)
Table 46. Global TB Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2034)
Table 47. Global TB Disease Vaccine Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 48. Global TB Disease Vaccine Sales by Application (2018-2024) & (K Units)
Table 49. Global TB Disease Vaccine Sales Market Share in Volume by Application (2018-2024)
Table 50. Global TB Disease Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 51. Global TB Disease Vaccine Sales Market Share in Value by Application (2018-2024)
Table 52. Global TB Disease Vaccine Price by Application (2018-2024) & (US$/Unit)
Table 53. Global TB Disease Vaccine Sales by Application (2024-2034) & (K Units)
Table 54. Global TB Disease Vaccine Sales Market Share in Volume by Application (2024-2034)
Table 55. Global TB Disease Vaccine Sales by Application (2024-2034) & (US$ Million)
Table 56. Global TB Disease Vaccine Sales Market Share in Value by Application (2024-2034)
Table 57. Global TB Disease Vaccine Price by Application (2024-2034) & (US$/Unit)
Table 58. North America TB Disease Vaccine Sales by Application (2018-2024) (K Units)
Table 59. North America TB Disease Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 60. Europe TB Disease Vaccine Sales by Application (2018-2024) (K Units)
Table 61. Europe TB Disease Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 62. Asia-Pacific TB Disease Vaccine Sales by Application (2018-2024) (K Units)
Table 63. Asia-Pacific TB Disease Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 64. Latin America TB Disease Vaccine Sales by Application (2018-2024) (K Units)
Table 65. Latin America TB Disease Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 66. Middle East and Africa TB Disease Vaccine Sales by Application (2018-2024) (K Units)
Table 67. Middle East and Africa TB Disease Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 68. North America TB Disease Vaccine Sales by Country (2018-2024) & (K Units)
Table 69. North America TB Disease Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 70. North America TB Disease Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 71. North America TB Disease Vaccine Sales Market Share in Value by Country (2018-2024)
Table 72. North America TB Disease Vaccine Sales by Country (2024-2034) & (K Units)
Table 73. North America TB Disease Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 74. North America TB Disease Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 75. North America TB Disease Vaccine Sales Market Share in Value by Country (2024-2034)
Table 76. Europe TB Disease Vaccine Sales by Country (2018-2024) & (K Units)
Table 77. Europe TB Disease Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 78. Europe TB Disease Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 79. Europe TB Disease Vaccine Sales Market Share in Value by Country (2018-2024)
Table 80. Europe TB Disease Vaccine Sales by Country (2024-2034) & (K Units)
Table 81. Europe TB Disease Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 82. Europe TB Disease Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 83. Europe TB Disease Vaccine Sales Market Share in Value by Country (2024-2034)
Table 84. Asia-Pacific TB Disease Vaccine Sales by Region (2018-2024) & (K Units)
Table 85. Asia-Pacific TB Disease Vaccine Sales Market Share in Volume by Region (2018-2024)
Table 86. Asia-Pacific TB Disease Vaccine Sales by Region (2018-2024) & (US$ Million)
Table 87. Asia-Pacific TB Disease Vaccine Sales Market Share in Value by Region (2018-2024)
Table 88. Asia-Pacific TB Disease Vaccine Sales by Region (2024-2034) & (K Units)
Table 89. Asia-Pacific TB Disease Vaccine Sales Market Share in Volume by Region (2024-2034)
Table 90. Asia-Pacific TB Disease Vaccine Sales by Region (2024-2034) & (US$ Million)
Table 91. Asia-Pacific TB Disease Vaccine Sales Market Share in Value by Region (2024-2034)
Table 92. Latin America TB Disease Vaccine Sales by Country (2018-2024) & (K Units)
Table 93. Latin America TB Disease Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 94. Latin America TB Disease Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 95. Latin America TB Disease Vaccine Sales Market Share in Value by Country (2018-2024)
Table 96. Latin America TB Disease Vaccine Sales by Country (2024-2034) & (K Units)
Table 97. Latin America TB Disease Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 98. Latin America TB Disease Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 99. Latin America TB Disease Vaccine Sales Market Share in Value by Country (2024-2034)
Table 100. Middle East and Africa TB Disease Vaccine Sales by Country (2018-2024) & (K Units)
Table 101. Middle East and Africa TB Disease Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 102. Middle East and Africa TB Disease Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 103. Middle East and Africa TB Disease Vaccine Sales Market Share in Value by Country (2018-2024)
Table 104. Middle East and Africa TB Disease Vaccine Sales by Country (2024-2034) & (K Units)
Table 105. Middle East and Africa TB Disease Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 106. Middle East and Africa TB Disease Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 107. Middle East and Africa TB Disease Vaccine Sales Market Share in Value by Country (2024-2034)
Table 108. Merck Company Information
Table 109. Merck Introduction and Business Overview
Table 110. Merck TB Disease Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 111. Merck TB Disease Vaccine Product
Table 112. Merck Recent Development
Table 113. Japan BCG Lab Company Information
Table 114. Japan BCG Lab Introduction and Business Overview
Table 115. Japan BCG Lab TB Disease Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 116. Japan BCG Lab TB Disease Vaccine Product
Table 117. Japan BCG Lab Recent Development
Table 118. Serum Institute of India Company Information
Table 119. Serum Institute of India Introduction and Business Overview
Table 120. Serum Institute of India TB Disease Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 121. Serum Institute of India TB Disease Vaccine Product
Table 122. Serum Institute of India Recent Development
Table 123. AJ Vaccines Company Information
Table 124. AJ Vaccines Introduction and Business Overview
Table 125. AJ Vaccines TB Disease Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 126. AJ Vaccines TB Disease Vaccine Product
Table 127. AJ Vaccines Recent Development
Table 128. BioFarma Company Information
Table 129. BioFarma Introduction and Business Overview
Table 130. BioFarma TB Disease Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 131. BioFarma TB Disease Vaccine Product
Table 132. BioFarma Recent Development
Table 133. GreenSignal Bio Pharma Company Information
Table 134. GreenSignal Bio Pharma Introduction and Business Overview
Table 135. GreenSignal Bio Pharma TB Disease Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 136. GreenSignal Bio Pharma TB Disease Vaccine Product
Table 137. GreenSignal Bio Pharma Recent Development
Table 138. China National Biotec Company Information
Table 139. China National Biotec Introduction and Business Overview
Table 140. China National Biotec TB Disease Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 141. China National Biotec TB Disease Vaccine Product
Table 142. China National Biotec Recent Development
Table 143. Biomed Lublin Company Information
Table 144. Biomed Lublin Introduction and Business Overview
Table 145. Biomed Lublin TB Disease Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 146. Biomed Lublin TB Disease Vaccine Product
Table 147. Biomed Lublin Recent Development
Table 148. Taj Pharmaceuticals Company Information
Table 149. Taj Pharmaceuticals Introduction and Business Overview
Table 150. Taj Pharmaceuticals TB Disease Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 151. Taj Pharmaceuticals TB Disease Vaccine Product
Table 152. Taj Pharmaceuticals Recent Development
Table 153. Ataulpho de Paiva Company Information
Table 154. Ataulpho de Paiva Introduction and Business Overview
Table 155. Ataulpho de Paiva TB Disease Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 156. Ataulpho de Paiva TB Disease Vaccine Product
Table 157. Ataulpho de Paiva Recent Development
Table 158. IVAC Company Information
Table 159. IVAC Introduction and Business Overview
Table 160. IVAC TB Disease Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 161. IVAC TB Disease Vaccine Product
Table 162. IVAC Recent Development
Table 163. Queen Saovabha Mem. Inst Company Information
Table 164. Queen Saovabha Mem. Inst Introduction and Business Overview
Table 165. Queen Saovabha Mem. Inst TB Disease Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 166. Queen Saovabha Mem. Inst TB Disease Vaccine Product
Table 167. Queen Saovabha Mem. Inst Recent Development
Table 168. Microgen Company Information
Table 169. Microgen Introduction and Business Overview
Table 170. Microgen TB Disease Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 171. Microgen TB Disease Vaccine Product
Table 172. Microgen Recent Development
Table 173. Key Raw Materials Lists
Table 174. Raw Materials Key Suppliers Lists
Table 175. TB Disease Vaccine Market Trends
Table 176. TB Disease Vaccine Market Drivers
Table 177. TB Disease Vaccine Market Challenges
Table 178. TB Disease Vaccine Market Restraints
Table 179. TB Disease Vaccine Distributors List
Table 180. TB Disease Vaccine Downstream Customers
Table 181. Research Programs/Design for This Report
Table 182. Key Data Information from Secondary Sources
Table 183. Key Data Information from Primary Sources
List of Figures
Figure 1. TB Disease Vaccine Product Picture
Figure 2. Global TB Disease Vaccine Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global TB Disease Vaccine Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global TB Disease Vaccine Sales Status and Outlook (2018-2034) & (K Units)
Figure 5. Product Picture of Prevention Vaccines
Figure 6. Global Prevention Vaccines Sales YoY Growth (2018-2034) & (K Units)
Figure 7. Product Picture of Post-exposure Vaccines
Figure 8. Global Post-exposure Vaccines Sales YoY Growth (2018-2034) & (K Units)
Figure 9. Product Picture of Others
Figure 10. Global Others Sales YoY Growth (2018-2034) & (K Units)
Figure 11. Global TB Disease Vaccine Sales by Type (2018-2034) & (US$ Million)
Figure 12. Global TB Disease Vaccine Sales Market Share by Type in 2022 & 2034
Figure 13. North America TB Disease Vaccine Sales Market Share in Volume by Type in 2022
Figure 14. North America TB Disease Vaccine Sales Market Share in Value by Type in 2022
Figure 15. Europe TB Disease Vaccine Sales Market Share in Volume by Type in 2022
Figure 16. Europe TB Disease Vaccine Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific TB Disease Vaccine Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific TB Disease Vaccine Sales Market Share in Value by Type in 2022
Figure 19. Latin America TB Disease Vaccine Sales Market Share in Volume by Type in 2022
Figure 20. Latin America TB Disease Vaccine Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa TB Disease Vaccine Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa TB Disease Vaccine Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by TB Disease Vaccine Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by TB Disease Vaccine Revenue in 2022
Figure 25. TB Disease Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 26. Product Picture of Self-Procurement
Figure 27. Global Self-Procurement Sales YoY Growth (2018-2034) & (K Units)
Figure 28. Product Picture of UNICEF
Figure 29. Global UNICEF Sales YoY Growth (2018-2034) & (K Units)
Figure 30. Product Picture of Others
Figure 31. Global Others Sales YoY Growth (2018-2034) & (K Units)
Figure 32. Global TB Disease Vaccine Sales by Application (2018-2034) & (US$ Million)
Figure 33. Global TB Disease Vaccine Sales Market Share by Application in 2022 & 2034
Figure 34. North America TB Disease Vaccine Sales Market Share in Volume by Application in 2022
Figure 35. North America TB Disease Vaccine Sales Market Share in Value by Application in 2022
Figure 36. Europe TB Disease Vaccine Sales Market Share in Volume by Application in 2022
Figure 37. Europe TB Disease Vaccine Sales Market Share in Value by Application in 2022
Figure 38. Asia-Pacific TB Disease Vaccine Sales Market Share in Volume by Application in 2022
Figure 39. Asia-Pacific TB Disease Vaccine Sales Market Share in Value by Application in 2022
Figure 40. Latin America TB Disease Vaccine Sales Market Share in Volume by Application in 2022
Figure 41. Latin America TB Disease Vaccine Sales Market Share in Value by Application in 2022
Figure 42. Middle East and Africa TB Disease Vaccine Sales Market Share in Value by Application in 2022
Figure 43. Key Raw Materials Price
Figure 44. TB Disease Vaccine Manufacturing Cost Structure
Figure 45. TB Disease Vaccine Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries